Korsana Biosciences (KRSA) Debt by Year
Korsana Biosciences, Inc. held $154.1M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Korsana Biosciences, Inc. has filed alongside them.
Ticker history: CYCN became KRSA (Korsana Biosciences, Inc.) on . Earlier news and filings retain their original names and dates. View CYCN history.
Annual figures, oldest first. Point at a bar to read its period.
KRSA Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
KRSA Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'26Filing | Q4'25Filing | Q3'25Filing | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $456.2M+9887.3% | $1.4M-53.7% | $2.8M-22.4% | $154.1M+4669.0% | $4.6M+59.1% | $3.0M-34.5% | $3.6M-36.1% | $3.2M-57.3% | $2.9M-68.5% | $4.6M-18.7% | $5.7M-20.5% | $7.6M-43.4% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Korsana Biosciences, Inc. financials
Frequently Asked Questions
Korsana Biosciences, Inc. held $154.1M in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Korsana Biosciences, Inc. (KRSA) reported on that line in every period on record.